HLA-G and cancer: HLA-G CAR competes with inhibitory receptors of NK cells (LILRB1 and KIR2D4) to bind HLA-G on malignant tumors, contributing to the upregulation of phosphor-Syk/Zap70 and the downregulation of phosphor-SHP-1 [159].